Sudeep Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
974.15
15.2 (1.59%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 6.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
158.27
182.34
172.34
162.67
124.92
157.55
115.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
158.27
182.34
172.34
162.67
124.92
157.55
115.54
Raw Material Cost
68.81
71.14
70.26
70.48
57.63
63.38
51.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-12.21
-7.28
-10.07
-9.54
-15.31
-3.61
-13.68
Employee Cost
14.34
10.52
15.04
14.10
12.24
10.94
9.68
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
32.43
45.37
37.14
32.17
26.48
28.06
28.62
Total Expenditure (Excl Depreciation)
103.36
119.75
112.37
107.21
81.04
98.77
76.24
Operating Profit (PBDIT) excl Other Income
54.91
62.59
59.97
55.46
43.88
58.78
39.30
Other Income
5.45
6.42
6.84
10.17
5.16
3.76
2.44
Operating Profit (PBDIT)
60.36
69.01
66.81
65.63
49.04
62.54
41.74
Interest
2.06
2.44
1.17
2.28
1.71
1.85
1.41
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
58.30
66.57
65.64
63.35
47.33
60.69
40.33
Depreciation
4.00
3.88
3.86
3.81
3.25
2.83
2.67
Profit Before Tax
54.29
62.69
61.78
59.53
44.07
57.85
37.66
Tax
13.71
14.15
14.08
12.76
12.80
13.67
8.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.59
48.54
47.70
46.78
31.27
44.19
28.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.59
48.54
47.70
46.78
31.27
44.19
28.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.04
-0.34
0.24
1.03
0.46
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
40.55
48.88
47.46
45.75
30.81
44.19
28.71
Equity Capital
11.29
11.29
11.29
9.72
9.72
9.72
9.72
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.59
4.33
4.2
4.71
3.17
4.55
0.3
Diluted Earnings per share
3.59
4.38
4.29
4.2
2.84
4.07
0.27
Operating Profit Margin (Excl OI)
34.69%
34.33%
34.8%
34.09%
35.13%
37.31%
34.01%
Gross Profit Margin
36.84%
36.51%
38.09%
38.94%
37.89%
38.52%
34.91%
PAT Margin
25.65%
26.62%
27.68%
28.76%
25.03%
28.05%
24.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 31.82% vs -11.20% in Mar 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 31.28% vs -4.09% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 35.65% vs -2.43% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -10.66% vs 212.70% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Sudeep Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
158.27
0
158.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
158.27
0
158.27
Raw Material Cost
68.81
0
68.81
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-12.21
0
-12.21
Employee Cost
14.34
0
14.34
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
32.43
0.00
32.43
Total Expenditure (Excl Depreciation)
103.36
0
103.36
Operating Profit (PBDIT) excl Other Income
54.91
0.00
54.91
Other Income
5.45
0
5.45
Operating Profit (PBDIT)
60.36
0
60.36
Interest
2.06
0
2.06
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
58.30
0
58.30
Depreciation
4.00
0
4.00
Profit Before Tax
54.29
0
54.29
Tax
13.71
0
13.71
Provisions and contingencies
0.00
0
0.00
Profit After Tax
40.59
0
40.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
40.59
0
40.59
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.04
0
0.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40.55
0
40.55
Equity Capital
11.29
0
11.29
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.59
0
3.59
Diluted Earnings per share
3.59
0
3.59
Operating Profit Margin (Excl OI)
34.69%
0%
0.00
34.69%
Gross Profit Margin
36.84%
0%
0.00
36.84%
PAT Margin
25.65%
0%
0.00
25.65%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 105.68 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 31.82% vs -11.20% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 31.82%

Quarterly - Standalone Net Profit
Standalone Net Profit 33.83 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 31.28% vs -4.09% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 34.25%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.19 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 35.65% vs -2.43% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 28.96%

Quarterly - Interest
Interest 1.76 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -10.66% vs 212.70% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 22.22%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.08%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025